This International Day of Women and Girls in Science, DRIFCan is proud to spotlight Rena Pawlick, a researcher in the Shapiro Lab whose work is bringing us closer to a cure for Type 1 diabetes.
Like many scientists, Rena discovered her passion early in life. She excelled in science and math as a student, but was also drawn to subjects like English and literature. She has both a scientific and a creative side, a combination that continues to guide her work today.
“I think a person who works in research needs to be creative and curious. We look for answers, but we also ask the questions because we are curious.”
A close connection to Type 1 diabetes
Rena has worked with Dr. Shapiro for 20 years. Her dedication to diabetes research is deeply personal. Her older sister lived with Type 1 diabetes from the age of seven. Growing up alongside her, Rena understands the day-to-day realities and long-term impacts all too well.
“Insulin is not a cure. My sister was on insulin from the age of seven. She passed away much too young at the age of 49 from complications related to diabetes.”
That loss continues to fuel Rena’s work today.
“What motivates me is her, of course, and also knowing that our research has an impact.”
Unlocking new possibilities with stem cell therapy
Rena’s work in the Shapiro Lab focuses on stem cell therapy, a field that holds enormous promise for those relying on insulin injections to manage their diabetes.
“We are in an exciting era in science. We can now switch the dial on cells. By taking a simple blood draw from an individual, we can reprogram them and differentiate them into insulin-producing cells—your own insulin-producing cells.”
This work isn’t easy. There are hurdles, and optimization takes time. Each advancement brings the team closer to improving the cell manufacturing process and ultimately achieving a cure.
However, the financial realities can’t be ignored.
“The cost in the area of research we are in right now is astronomical. As an academic institute, we rely on grant money and donation in-kind.”
Help fund the cure
This is where community support makes a real difference. DRIFCan directs 90% of all dollars raised directly to cure-focused diabetes research, ensuring Rena and the rest of the team have the resources they need to continue this groundbreaking work.
Help us fund the cure and change the future for those living with Type 1 diabetes: drifcan.com/support.